Stemtech Corp
OTC:STEK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Saturday Co Ltd
SZSE:002291
|
CN |
|
Nerdy Inc
NYSE:NRDY
|
US |
Stemtech Corp
EPS (Diluted)
Stemtech Corp
EPS (Diluted) Peer Comparison
Stemtech Corp
Glance View
Stemtech Corp. engages in the development of nutritional supplements. The company is headquartered in Naples Florida, Florida and currently employs 45 full-time employees. The company went IPO on 2014-09-15. The firm is also known as Stem Cell Nutrition Company. The firm's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The firm markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). The company also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.
See Also
What is Stemtech Corp's EPS (Diluted)?
EPS (Diluted)
-0
USD
Based on the financial report for Dec 31, 2024, Stemtech Corp's EPS (Diluted) amounts to -0 USD.
What is Stemtech Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
46%
Over the last year, the EPS (Diluted) growth was 57%. The average annual EPS (Diluted) growth rates for Stemtech Corp have been 46% over the past three years .
